Analysts Adjust Price Targets for HCA Healthcare
Multiple financial institutions, including Jefferies, BofA, and KeyBanc, updated their price targets for HCA Healthcare on October 28, 2026.
Stocks · News reference
HCA Healthcare beat Q3 estimates: revenue rose 3.6% to $19.85B, EPS hit $7.22, and FY26 guidance increased; analysts raised price targets.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Multiple financial institutions, including Jefferies, BofA, and KeyBanc, updated their price targets for HCA Healthcare on October 28, 2026.
KeyBanc analyst Matthew Gillmor has maintained a buy rating on HCA Healthcare while increasing the price target to $490.